Skip Navigation

Cell and Molecular Biology


Objectives
The Cell and Molecular Biology Core:

Specific Services

Advice and Training in Cell and Molecular Biology Techniques
The core can provide advice regarding the design and interpretation of experiments using basic molecular techniques such as PCR, transfections, etc. The core can assist with the computer analysis of DNA or protein sequences. Users who have highly specialized needs that require expertise beyond the core will be referred to other appropriate laboratories where feasible.

Transgenic Animal and Vector Core Facility Subsidies
The MDRTC Cell and Molecular Biology Core can provide limited subsidies (typically 25% of cost, though the total subsidy for each laboratory may be capped) to users of the Biomedical Research Council Transgenic Animal and Vector Core Facilities. A Transgenic Animal Core Subsidy Application or a Vector Core Subsidy Application should be completed and submitted via the Web. The application will be reviewed, and you will be notified of approval/ disapproval. To be potentially eligible for the subsidy, the project must be relevant to diabetes or related endocrine disorders, and this relationship must be clearly justified on the application form. For the purpose of these applications, “related endocrine disorders” are those that impact diabetes, such as obesity.

Microarray Analysis
Gene expression profiling using Affymetrix GeneChips is available at a discounted rate through the Cancer Center Microarray Facility. To be potentially eligible for the subsidy, a Microarray application form should be filled out and submitted via the Web. The application will be reviewed, and you will be notified of approval/ disapproval.The project must be relevant to diabetes or related endocrine disorders, and this relationship must be clearly justified on the application form. For the purpose of this application, “related endocrine disorders” are those that impact diabetes, such as obesity. Microarray analysis is very expensive. The MDRTC typically will provide a 25% discount, though the total subsidy for each laboratory may be capped.

Hybridoma Core
The MDRTC will continue to provide subsidies for use of the Hybridoma Core, typically equal to 50% of charges, though the total subsidy for each laboratory may be capped. Please see the Hybridoma Core web site. To be potentially eligible for the subsidy, the project must be relevant to diabetes or related endocrine disorders. “Related endocrine disorders” are those that impact diabetes, such as obesity.

RNA interference / shRNA lentiviral plasmids
The UM Functional Genomics Core (3338 LSI; 615-5309; http://fgc.lsi.umich.edu) houses, maintains and distributes lentivrial plasmid vectors expressing shRNAs directed against most mouse and human genes, to be used in RNA interference gene silencing studies. The MDRTC Cell & Molecular Biology Core will provide a 50% subsidy toward the purchase of these shRNAs, though the total subsidy for each laboratory may be capped. An application form is not necessary. There should be an MDRTC check box on the UM Functional Genomics Core request form, which will trigger the subsidy.

High Throughput Chemical Screens (Center for Chemical Genomics, 3338 LSI, 615-9422, http://www.lsi.umich.edu/ccg)
The Center for Chemical Genomics performs high throughput robotics screens of a library of ~50,000 small molecules to identify compounds that activate or inhibit a biological process of interest. Typical goals are to either: a) identify novel chemicals to rapidly activate or inhibit the process and study the biological consequences; or b) find potential leads for the identification of useful drugs. The MDRTC can subsidize 1 or 2 users per year at 50% of the cost up to $10,000 per PI. (We will subsidize the actual small molecule screen, after assay development is complete). The project should be discussed with the CGC directly to assess feasibility and to develop the screening assay. The CCG form contains an “Other Funding Information” box; you apply for the subsidy by writing MDRTC in that box. To be potentially eligible for the subsidy, the project must be relevant to diabetes or related endocrine disorders. “Related endocrine disorders” are those that impact diabetes, such as obesity.

Bacterial Artificial Chromosome Recombineering Core
Bacterial Artificial Chromosomes (BACs) are plasmid-like constructs that can be grown in E. coli and that contain genomic DNA fragments of ~200 kb. BACs are commercially available that contain most of the genes from human, mouse and other species. These can be modified (“recombineered”) by insertion, deletion or point mutation, and can then be used as targeting vectors to modify endogenous genes in mice, or to produce transgenic mice. Thus, BACs can be used to create mouse models of human diseases and to make mice expressing reporter genes. Since BAC recombineering is technically demanding, the BAC Recombineering Core has been established.

The BAC Recombineering Core is fully operational as of October 2009.
This core is managed by Thom Saunders tsaunder@umich.edu and functionally is part of the Transgenic Animal Model Core. The MDRTC provides substantial support for the BAC Recombineering Core, therefore MDRTC members utilize its services at a significant discount. MDRTC investigators will be charged $500 for BAC recombineering (per construct), and $25 for BAC DNA purification including pulsed field gel verification of restriction enzyme fragments. The BAC Recombineering application should be completed and sent to 2560 MSRB II, Box 0674.

Equipment

The equipment described below is available to MDRTC members and is located in room 5570-E MSRB-II. Room keys cannot be provided to users, and the room must be kept locked when it is not in use. We regret the inconvenience, but this means that users may not have reliable access during non-business hours. Users must first receive training by Dr. Ron Koenig before they will be able to access the equipment.

The following equipment is available to MDRTC members in room 6235 of the Brehm Tower:

Key Personnel

Ronald J. Koenig, M.D., Ph.D., Core Director, rkoenig@umich.edu; 734-615-9497